OMITTED

What the news leaves out.

← Omitted front page

Ex-RFK Jr Adviser Calley Means Blasts White House on MAHA Agenda

11 sources · updated 2026-11-09
Calley Means
Photo: Gage Skidmore from Surprise, AZ, United States of America / Wikimedia Commons · CC BY-SA 2.0 · file · licence
Left 27% Center 64% Right 9%
3 left · 7 center · 1 right

What happened

In early November 2026, Calley Means, a former senior White House adviser and top aide to Health and Human Services Secretary Robert F. Kennedy Jr., went public with detailed allegations that senior Trump administration officials had undermined the "Make America Healthy Again" (MAHA) health agenda in order to serve corporate donors. In a long-form interview on "The Joe Rogan Experience" taped the first week of November and a televised interview on CBS News’ "Face the Nation" aired Nov. 8, Means named then–White House chief of staff Susie Wiles and several aides as having catered to industries including vaping, ultra‑processed food, pharmaceuticals and pesticides, while citing the need for midterm campaign money. Wiles submitted her resignation to President Trump on the Thursday before the CBS interview, after Republican midterm election losses; she and other named officials, as well as pollster Tony Fabrizio and lobbying firm Continental Strategy, issued statements denying Means’ claims or disputing his characterizations of their roles. CBS News further reported, based on multiple sources and Federal Election Commission records, that Trump had personally sought to expand access to flavored vapes and that a tobacco affiliate donated $5 million to a pro‑Trump PAC a week before a key vape policy rollout. The Hill separately reported that Means asked for records related to Wiles’ influence on health policy to be preserved, while NewsNation highlighted his claim that internal resistance blocked key MAHA initiatives such as defining ultra‑processed food and tightening rules on glyphosate and kratom.
Sourcing check · Fully on the record · 11 articles

9 of 9 articles cite a named source for the story. It was on the record from the first report. James Blair denied part of it on the record.

What these terms mean and how they're counted
On the record · names a source 9 of 9
On the record means the article cites a source by name for the story's main claim: a person, or an institution speaking officially, such as a company statement or a named agency's spokesperson. The opposite is an unnamed source. The count is how many of the counted articles cite at least one such source; the names are everyone named across them, each once however the articles spell it. Here: Calley Means
Primary evidence · cites a document or data 2 of 9
Primary evidence means the article cites a record you could check yourself: a court filing or ruling, a dataset or report, a recording or transcript, an official statement or press release, market data. A quote is not a document. The count is how many articles cite one. Here: transcript
Credits another outlet 0 of 9
The article says the story comes from another outlet's reporting (“first reported by Reuters”). Those articles relay the story; they are not independent confirmation. Here: Each article presents its own reporting.
Unnamed sources 0 of 9
The main claim is attributed to people who are not identified: “people familiar with the matter”, “officials said”. The count is how many articles do this.
On-record denial 1
A named person or institution says the claim, or part of it, is not true. It is on the record — someone signed their name to it — but it is not confirmation, so it never counts toward On the record. Criticizing or dissenting from a decision is not a denial. The count is how many people or institutions deny it; each is listed with the first article that carried the denial. Here: James Blair (CBS News, Nov 8, 21:46 UTC)
How it developed
When the first report landed and whether it named anyone; when the first named source and the first document appeared. Here: First report Nov 6, 18:52 UTC by Axios, naming its source. First document the next day, from CBS News (transcript).
Not counted 2
Opinion, analysis and video pieces, and articles too short to assess. Every count above is out of the counted articles. An article republished under a new headline is one article.
This is about who is cited, not whether the story is true. Each source below says what it names. How we count
Omitted — what each side leaves out

Unpacked

The biggest gap is that right‑leaning coverage casts the problem as rogue staff thwarting Trump, but omits evidence that Trump himself advanced some of the same industry‑friendly policies. CBS reports that he vowed to “save” vaping, that sources say he personally wanted flavored vapes more available, and that a Reynolds American affiliate gave $5 million to a pro‑Trump PAC a week before a favorable tobacco policy rollout. Without this, a reader may see Wiles as the main villain; with it, the story looks more like a president and his team jointly navigating, and benefiting from, corporate influence. A secondary pattern is how each side treats Means’ own potential conflicts. Left‑leaning coverage notes that Democrats flagged his past $25–50 million stake in Truemed and that he admits he “didn’t love” MAHA’s alignment with big sponsors like Walmart, while the Washington Examiner profile simply presents him as a whistleblower blaming “nepotism” for stalling priorities, without mentioning his financial history or MAHA’s own corporate ties. One side scrutinizes his credibility; the other uses his claims mainly to reinforce an anti‑swamp narrative. The obvious unasked question is: if both the president and his reformist aides benefited from or courted some of these same industries, who actually has clean hands to remake health policy?
Bottom line

Coverage on the right highlights Calley Means blaming Susie Wiles for betraying Trump’s MAHA agenda, but only CBS spells out that Trump himself pushed to “save” vaping and received a $5 million tobacco‑sector donation just before a key vape policy decision, shifting the story from one bad chief of staff to a broader question about how far up corporate influence really goes.

The receipts — 5 facts one side's coverage lacks
  • An affiliate of Reynolds American donated $5 million to the pro‑Trump MAGA Inc. PAC a week before the administration rolled out a new, more favorable tobacco policy, while sources say Trump personally wanted flavored vapes more available and had campaigned to "save" vaping. numberin CBS News · absent from right-leaning coverage
  • Susie Wiles, James Blair, Heidi Overton, Tony Fabrizio and Continental Strategy all issued specific statements denying or disputing Means’ allegations about their roles in vape policy, glyphosate litigation and lobbying ties. official statementin CBS News · absent from right-leaning coverage
  • Means previously owned between $25 million and $50 million in stock in Truemed, a company positioned to benefit from channeling medical spending to food and fitness, and Democrats have raised this as a possible ethics issue from his time as a special government employee. numberin CBS News · absent from right-leaning coverage
  • The recent MAHA conference featured major corporate sponsors such as Walmart and UnitedHealthcare, and Means said he "didn't love" the optics of that alignment. contextin CBS News · absent from right-leaning coverage
  • The Trump administration, through a solicitor‑general brief that aligned with Monsanto/Bayer, urged the Supreme Court to take a glyphosate liability case and argued that federal standards should pre‑empt state‑level claims, supporting limits on Roundup lawsuits. contextin CBS News · absent from right-leaning coverage
The Left View
Left‑leaning coverage centers Means’ allegations as an example of internal MAGA corruption and corporate capture of health policy. The Hill highlights his charge that Susie Wiles led a White House that “bowed to corporate interests” on MAHA priorities and notes his formal request to preserve records of her policy involvement. CBS’ framing stresses specific instances where MAHA initiatives were allegedly slowed or reversed: the scrapped federal definition of ultra‑processed food after lobbying by Coca‑Cola and Mondelez; pressure to approve fruit‑flavored vapes and to ease limits on kratom (“gas station heroin”); and support for glyphosate producer Bayer/Monsanto in Supreme Court litigation. This side also foregrounds counter‑evidence and conflicts: denials from Wiles, James Blair, Heidi Overton, Tony Fabrizio and Continental Strategy; the administration’s explanation that the solicitor general, not MAHA staff, led the glyphosate brief; and questions about Means’ own ethics, including his past $25–50 million stake in Truemed and MAHA’s ties to corporate sponsors like Walmart and UnitedHealthcare. Left‑leaning outlets underscore that MAHA itself is politically fraught, especially around vaccines and RFK Jr.’s mRNA skepticism, and that some Democrats are talking about hearings or even impeaching Kennedy, suggesting the dispute is part of a broader fight over how politicized health regulation has become.
The Right View
Right‑leaning coverage presents the story primarily as a reformer’s revolt against entrenched insiders who sabotaged Trump’s promised health agenda. The Washington Examiner emphasizes that Means, described as a former senior HHS adviser, “did not hold back” in blaming Susie Wiles and what he calls nepotism—particularly her daughter’s work at a lobbying firm—for stalling Make America Healthy Again priorities championed by RFK Jr. This framing portrays MAHA’s goals (healthier food, tackling pesticides and ultra‑processed foods, lowering drug costs) as broadly popular but obstructed by a small, self‑interested White House clique aligned with K Street. Trump and Kennedy are cast as essentially aligned with Means, while Wiles and her “cohort” are singled out as having slowed or derailed reforms. Right‑leaning discussion focuses on palace‑intrigue elements—internal fights, resignations, and Means’ dramatic criticism of Wiles—rather than on the detailed disputes over specific policies like flavored vapes, glyphosate litigation strategy, or the internal ethics questions raised about MAHA figures themselves.
Our Take (balanced)
The left’s strongest case is that Means’ account, taken in full, illustrates a pattern of corporate influence that implicates not just staff but the broader MAGA–MAHA project: CBS documents how vape and glyphosate decisions aligned with industry positions, shows Trump personally campaigned to “save” vaping, and details large donations from tobacco interests, while also noting that several of Means’ most explosive claims are directly contradicted by the officials he accuses and by a senior White House account of the glyphosate brief. The right’s strongest case is that Means offers a rare, inside‑the‑room narrative with specific names, timelines and anecdotes—such as food lobbyists threatening to “call Susie’s office” and Ballard Partners’ record lobbying revenues—that is consistent with broader concerns about Washington’s revolving door and suggests popular, low‑cost health measures were blocked for donor politics rather than policy merit. The unresolved core tension is whether this episode primarily reveals a president and health secretary earnestly pursuing reform while being undermined by self‑dealing aides, as Means insists, or whether it instead shows a more systemic and politically selective pattern of capture—where both MAHA advocates and their internal opponents have competing financial and ideological stakes, and the line between reform and factional power struggle is itself blurred.

11 sources

More stories

The week's bottom lines, in your inbox

One email a week: the five stories that mattered and what they actually mean. Free.